Collectively, HJURP could promote ovarian cancer progression, and all findings had provided foundation for subsequent studies about HJURP downstream-regulated networks and potential value of silencing HJURP in ovarian cancer therapy. The gene discussed is HJURP; the disease is ovarian cancer.